Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review

Abstract Background The prognosis for patients with advanced differentiated thyroid carcinoma (ADTC) with disseminated distant metastases is very poor. Tyrosine kinase inhibitors targeting tumor angiogenesis have been shown to improve progression-free survival in patients with advanced thyroid carci...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nai-Wei Sheu, He-Jiun Jiang, Che-Wei Wu, Feng-Yu Chiang, Hsin-Ying Clair Chiou, Pi-Jung Hsiao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2019-05-01
coleção:	World Journal of Surgical Oncology
Assuntos:	Advanced thyroid carcinoma Lenvatinib Tyrosine kinase inhibitor (TKI)
Acesso em linha:	http://link.springer.com/article/10.1186/s12957-019-1626-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!